Medicare spending for three popular diabetes and weight loss drugs — Ozempic, Rybelsus, and Mounjaro — reached $5.7 billion in 2022, up from $57 million in 2018, according to research by KFF. The "outrageously high" price has "the potential to bankrupt Medicare, Medicaid, and our entire health care system," Sen.
May 20, 2024
People also ask
When will Ozempic be available again for diabetics?
What is the new warning about Ozempic?
Did Kelly Clarkson take Ozempic?
What is the Ozempic scandal?
Mar 27, 2024 · Ozempic has the potential to be a game changer in the diabetes and obesity epidemics in America. But, if we do not substantially reduce the ...
People also search for
Related conditions
For informational purposes only. Consult your local medical authority for advice.
Related health topics